Yusuf, Nabiha, Ph.D., MSPH

Principle Investigator

The focus of Dr. Nabiha Yusuf's research is to dissect the role of innate immune responses in UVB induced cutaneous DNA damage and tumor development. Her laboratory is studying the mechanisms by which type I interferons (IFN) regulate ultraviolet (UV) radiation induced cutaneous DNA damage and tumor development. She is also interested to dissect the role of type I IFNs in immunotherapy, infection associated cancers, and autoimmune disorders. She was recently funded with Dr. Hui Xu to study the role of Triggering receptor on myeloid cells (Trem)-1 in UV-induced immune suppression. She is also performing translational studies on Toll-like receptor-4 (TLR4) inhibitor in prevention of skin cancer. Her long-term goal is to perform epidemiological studies with correlative biomarkers in population with inflammatory diseases and cancers.